FIA
AVNS

FNY Investment Advisers’s Avanos Medical AVNS Stock Holding History

FNY Investment Advisers’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.58M Buy
+103,500
New +$2.42M 0.93% 18

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SRC
Samson Rock Capital London, United Kingdom $45.6M AUM 86.17% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
CIEC
Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return
TMAM
Tokio Marine Asset Management Tokyo, Japan $3.23B AUM 37.2% 1-Year Est. Return
KIM
Kestrel Investment Management San Mateo, California $184M AUM 31.66% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

FNY Investment Advisers's AVNS Position: Q2 2026 in Review

FNY Investment Advisers opened a new position in Avanos Medical (AVNS) in Q2 2026: 103,500 shares worth $2.58M. The stake represents 0.93% of the portfolio and ranks #18 among its holdings.

118 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • FNY Investment Advisers held 103,500 shares of Avanos Medical worth $2.58M as of Q2 2026.
  • Avanos Medical was a new FNY Investment Advisers position in Q2 2026.
  • Avanos Medical made up 0.93% of FNY Investment Advisers's portfolio in Q2 2026, its #18 holding.
  • 118 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.